CSGP vs TERN · P/E 484, rev $2.74B vs $6.12B cap
CoStar Group Inc (CSGP) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
CSGP currently screens at market cap $13.84B and trailing P/E 484.1. TERN currently screens at market cap $6.12B.
Not investment advice. Open the CSGP and TERN stock pages for the full models.
Not investment advice.